TRIM24 and gastric cancer: Studies in various cancers, including HCC [29], gastric cancer [91], ovarian cancer [36, 92], renal cell carcinoma [93, 94], colorectal cancer [97], and NSCLC [34], have demonstrated that down-regulation of TRIM24 reduces the migratory and invasive capabilities of cancer cells and influences the expression of EMT-related proteins.